Humana
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 3 days.
- Recent price momentum is +39.5% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has fallen to 2.3% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-21 20:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation C
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 38.0x | Better than 15% |
| Forward P/E | 21.6x | Better than 32% |
| Price / Sales | 0.3x | Better than 96% |
| P/E vs own 5-yr range | 95th pctl | Better than 9% |
Growth C-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 11.8% | Better than 69% |
| Net income CAGR (3Y) | -24.9% | Better than 14% |
| Free cash flow CAGR (3Y) | -52.3% | Better than 4% |
Profitability C
How much profit the business keeps from each dollar of sales and capital.
| Net margin | 0.9% | Better than 29% |
| Return on equity | 7.0% | Better than 41% |
Momentum A
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 2.9% | Better than 80% |
| 6-month return | 26.9% | Better than 88% |
| 12-month return (ex latest month) | 87.4% | Better than 94% |
| Distance below 52-week high | 15.7% | Better than 69% |
Financial Health C-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Debt to assets | 25.3% | Better than 48% |
| Interest coverage | 3.5x | Better than 48% |
| Free cash flow / net income | 31.6% | Better than 8% |
Analyst View B
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 76.2% | Better than 56% |
| Upside to average target | 31.9% | Better than 51% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 380.00
- Open
- 392.54
- Day range
- 387.83 - 401.98
- Avg price
- 393.46
- Volume
- 2.32M
- Turnover
- 911.56M
- Turnover ratei
- 1.93%
- Volume ratioi
- 0.98
- Amplitudei
- 3.73%
- 52-week rangei
- 161.56 - 462.87
Valuation
- P/Ei
- 39.63
- P/E (TTM)i
- 38.05
- P/Bi
- 2.49
- EPSi
- 9.84
- Book value / shi
- 156.74
- Net profit
- 1.18B
- Net assets
- 18.82B
Share structure
- Market cap
- 46.84B
- Float capi
- 46.74B
- Shares out
- 120.10M
- Float sharesi
- 119.86M
Dividend & listing
- Div yield (TTM)i
- 0.68%
- Dividend (TTM)
- 2.66
- Listing date
- 1970-01-01
15.7% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+39.02M net over the window
Short interest
- Shares short
- 2.78M
- % of floati
- 2.32%
- Days to coveri
- 2.15
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Humana (HUM)?
Humana last traded at 390.00. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Humana's market cap?
About 46.84B.
What is the P/E ratio of Humana?
The trailing twelve-month P/E is 38.05, above its own 5-year average of 22.74 — toward the top of its historical range (94.58% percentile). See the Valuation tab for the full history.
Does Humana pay a dividend?
Yes. The trailing dividend yield is 0.68%. The 2025 payout was little changed from 2024. See the Dividends tab for the full payment history.
Is Humana a buy according to analysts?
The consensus of 21 analysts is a Buy rating, with an average 12-month price target of 514.25, which implies 31.9% upside from the current price. This is not investment advice.
What is Humana's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Humana a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 20:01:19 · For reference only, not investment advice and not tailored to your situation.
Humana discussion 0 comments